Wei Duan
Impact in
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism
- Cancer Research top 1%
- MicroRNA in disease regulation
Papers in
-
- Advanced biosensing and bioanalysis techniques 44
- RNA Interference and Gene Delivery 43
- Extracellular vesicles in disease 14
- Oncology 49
- Cancer Cells and Metastasis 19
- Co-authors
- Sarah Shigdar (36 shared papers)Shu‐Feng Zhou (19 shared papers)Eli Chan (26 shared papers)Michael Croft (11 shared papers)Yong Li (26 shared papers)Xin‐Gui Li (6 shared papers)Sui Yung Chan (13 shared papers)Dongxi Xiang (21 shared papers)
- Journals
- Current Drug Metabolism (11 papers)International Journal of Pharmaceutics (9 papers)Cancer Letters (9 papers)Pharmaceutical Research (6 papers)Theranostics (6 papers)
- Partner nations
- ChinaAustraliaUnited States
In The Last Decade
Wei Duan
317 papers receiving 13.9k citations
Wei Duan's Hit Papers
Peers
Comparison fields: 5 of 176
- Pharmacology 1.0k
- Cancer Research 1.3k
- Molecular Biology 5.9k
- Complementary and alternative medicine 665
- Biomaterials 1.1k
Countries citing papers authored by Wei Duan
This map shows the geographic impact of Wei Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Duan more than expected).
Fields of papers citing papers by Wei Duan
This network shows the impact of papers produced by Wei Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Duan. The network helps show where Wei Duan may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Duan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 333 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel Multifunctional Polymers from Aromatic Diamines by Oxidative Polymerizations Hit paper breakdown → | 2002 | 628 |
| 2 | 2005 | 459 | |
| 3 | 2009 | 452 | |
| 4 | Selection of DNA Aptamers against Epithelial Cell Adhesion Molecule for Cancer Cell Imaging and Circulating Tumor Cell Capture Hit paper breakdown → | 2013 | 441 |
| 5 | 2005 | 396 | |
| 6 | 2013 | 273 | |
| 7 | 2020 | 263 | |
| 8 | 2004 | 249 | |
| 9 | 2005 | 204 | |
| 10 | 2011 | 203 | |
| 11 | 2019 | 196 | |
| 12 | 2013 | 190 | |
| 13 | 2014 | 188 | |
| 14 | 2013 | 182 | |
| 15 | 2014 | 174 | |
| 16 | 2011 | 174 | |
| 17 | 2015 | 170 | |
| 18 | 2020 | 160 | |
| 19 | 2013 | 159 | |
| 20 | 2013 | 157 |
About Wei Duan
Wei Duan is a scholar working on Molecular Biology, Oncology, Biomedical Engineering, Biomaterials and Immunology, having authored 333 papers that have together received 14.1k indexed citations. Recurring topics across this work include Advanced biosensing and bioanalysis techniques (44 papers), RNA Interference and Gene Delivery (43 papers), Nanoparticle-Based Drug Delivery (21 papers), Cancer Cells and Metastasis (19 papers), Extracellular vesicles in disease (14 papers), Pharmacogenetics and Drug Metabolism (12 papers), Immune Cell Function and Interaction (10 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Pharmacology (1.0k citations), Cancer Research (1.3k citations), Molecular Biology (5.9k citations), Complementary and alternative medicine (665 citations) and Biomaterials (1.1k citations). Wei Duan has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Sarah Shigdar, Shu‐Feng Zhou, Eli Chan, Michael Croft, Yong Li, Xin‐Gui Li, Sui Yung Chan, Dongxi Xiang, W.S. Fred Wong and Mei‐Rong Huang. Their work appears in journals such as Current Drug Metabolism, International Journal of Pharmaceutics, Cancer Letters, Pharmaceutical Research and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.